InVivo Therapeutics Holdings Corp (NVIV)

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a...  Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with InVivo Therapeutics Corporation.  और पढ़ें

• President, CEO, Chief Medical Officer & Director

  Dr. Richard M. Toselli M.D.

• President, CEO, Chief Medical Officer & Director

  Dr. Richard M. Toselli M.D.

• हेडक्वार्टर्स

  Cambridge, MA

• वेबसाइट

  https://www.invivotherapeutics.com